|

Lyumjev U-100 Insulin Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 2

Top Sponsors

  • Stanford University1
  • Portal Diabetes, Inc.1

Indications

  • Diabetes2
  • Type 1 Diabetes Mellitus1
  • Type 1 Diabetes1
  • Diabetes Mellitus, Type 11

Chula Vista, California1 trial

A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500

ProSciento, Inc.

Phase 1

Palo Alto, California1 trial

Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes

Stanford University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.